These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 436801)

  • 1. Half life of gastrointestinal glucagon-like immunoreactive materials.
    Tanaka R; Matsuyama T; Shima K; Sawazaki N; Tarui S; Kumahara Y
    Endocrinol Jpn; 1979 Feb; 26(1):59-63. PubMed ID: 436801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):33-8. PubMed ID: 6993193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hypophysectomy and hypophysis-transplantation on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in depancreatized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):77-81. PubMed ID: 6248336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin releasing activity of gastrointestinal glucagon-like immunoreactive materials in perfused rat pancreas.
    Tanaka R; Matsuyama T; Shima K; Sawazaki N; Tarui S; Kumahara Y
    Endocrinol Jpn; 1977 Dec; 24(6):575-9. PubMed ID: 606546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
    Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
    Larsson LI; Moody AJ
    J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastrointestinal hormones and related neuropeptides. IV. The secretion group: gastric inhibitory polypeptide (GIP), intestinal pancreatic glucagon-like immunoreactants (intestinal GLI) and PHI].
    Krowicki Z; Sadowska-Krowicka H; Zych F
    Postepy Hig Med Dosw; 1984; 38(4):513-34. PubMed ID: 6399110
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastric and pancreatic hyposecretion following massive small-bowel resection.
    Seal AM; Debas HT; Reynolds C; Said SI; Taylor IL
    Dig Dis Sci; 1982 Feb; 27(2):117-23. PubMed ID: 7075405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of glucagon- and GLI-containing cells in the canine gut and pancreas.
    Ito S; Kobayashi S
    Arch Histol Jpn; 1976 Jul; 39(3):193-202. PubMed ID: 788674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the relation between late dumping syndrome and glucagon responses to glucose].
    Matsui T
    Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):159-70. PubMed ID: 3073247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glucagon in the gastrointestinal tract.
    Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
    J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney.
    Kervran A; Dubrasquet M; Blache P; Martinez J; Bataille D
    Regul Pept; 1990 Oct; 31(1):41-52. PubMed ID: 2270317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Nonaka K; Tarui S
    Diabetologia; 1978 Dec; 15(6):471-4. PubMed ID: 720780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glicentin immunoreactive cells: their relationship to glucagon-producing cells.
    Ravazzola M; Siperstein A; Moody AJ; Sundby F; Jacobsen H; Orci L
    Endocrinology; 1979 Aug; 105(2):499-508. PubMed ID: 378654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-hormone profile in coeliac disease.
    Besterman HS; Bloom SR; Sarson DL; Blackburn AM; Johnston DI; Patel HR; Stewart JS; Modigliani R; Guerin S; Mallinson CN
    Lancet; 1978 Apr; 1(8068):785-8. PubMed ID: 85811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is GIP a glucagon cell constituent?
    Alumets J; Håkanson R; O'Dorisio T; Sjölund K; Sundler F
    Histochemistry; 1978 Dec; 58(4):253-7. PubMed ID: 104936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.
    Sjölund K; Ekelund M; Håkanson R; Moody AJ; Sundler F
    J Histochem Cytochem; 1983 Jun; 31(6):811-7. PubMed ID: 6188783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.